CJC-1295 (No DAC) 5mg

Description

CJC-1295 (No DAC) is an experimental synthetic peptide research compound investigated in peptide biology, receptor signaling, molecular endocrinology, growth-hormone-related pathways, cellular communication, and peptide–receptor interactions. Also referred to as Mod GRF 1-29, CJC-1295 (No DAC) is a modified growth hormone-releasing hormone (GHRH) analogue used as a research model for investigating GHRH receptor biology and related intracellular signaling mechanisms.

Unlike CJC-1295 formulations containing a Drug Affinity Complex (DAC), CJC-1295 (No DAC) represents the shorter modified GRF 1-29 research peptide. This distinction makes it particularly relevant to comparative peptide research examining molecular structure, receptor interactions, signaling characteristics, and peptide pharmacology.

For Research Use Only. Not intended for human or veterinary use, consumption, diagnosis, treatment, or prevention of disease.

---

CJC-1295 (No DAC) Research Profile

CJC-1295 (No DAC) is structurally related to the naturally occurring growth hormone-releasing hormone (GHRH) sequence and has been developed as a modified research analogue.

Its experimental research profile makes it relevant to investigations involving:

• GHRH receptor biology
• Peptide–receptor interactions
• Growth-hormone-related signaling
• Molecular endocrinology
• Peptide structure–function research
• Cellular signaling
• Intracellular communication
• Receptor pharmacology
• Molecular biology
• Experimental peptide science
• Biochemical research

The specific response observed in an experimental system depends on the model, receptor expression, assay design, controls, and analytical methodology.

---

GHRH Receptor & Molecular Signaling Research

A major area of research involving CJC-1295 (No DAC) is the study of GHRH receptor-mediated signaling.

GHRH receptors are members of the G protein-coupled receptor (GPCR) family. Experimental research can therefore examine how modified GHRH analogues interact with receptors and how receptor–ligand interactions relate to downstream intracellular signaling.

Potential research areas include:

• GHRH receptor signaling
• GPCR research
• Peptide–receptor binding
• Ligand–receptor interactions
• Signal transduction
• Intracellular signaling
• Molecular recognition
• Receptor pharmacology
• Cellular communication
• Peptide pharmacology

These applications describe scientific research areas and should not be interpreted as therapeutic recommendations.

---

Peptide Chemistry & Structure–Function Research

CJC-1295 (No DAC) is also relevant to research examining how specific modifications to peptide sequences influence molecular characteristics and receptor interactions.

Researchers may investigate:

• Peptide structure
• Peptide stability
• Structure–function relationships
• Molecular recognition
• Receptor binding
• Protein–peptide interactions
• Peptide chemistry
• Biomolecular interactions
• Chemical biology
• Molecular pharmacology

The distinction between DAC-containing and No-DAC research formulations can also be relevant to comparative studies examining how structural modifications affect experimental peptide behavior.

---

Growth-Hormone-Related Molecular Research

Because CJC-1295 (No DAC) is a GHRH analogue, it is relevant to laboratory research examining growth-hormone-related molecular signaling and endocrine pathways.

Potential research areas include:

• Growth-hormone-related signaling
• GHRH biology
• Endocrine receptor research
• Molecular endocrinology
• Peptide signaling
• Receptor-mediated cellular communication
• Hormone receptor biology
• Cellular pathway analysis
• Experimental endocrine biology

Research conducted using cellular or other experimental models should be interpreted within the limitations of those models rather than extrapolated directly to human outcomes.

---

Laboratory Research Applications

CJC-1295 (No DAC) may be relevant to appropriately designed investigations involving peptide and receptor biology.

Potential research applications include:

• GHRH receptor research
• GPCR signaling studies
• Peptide–receptor interaction research
• Growth-hormone-related molecular research
• Molecular biology
• Cellular signaling
• Molecular endocrinology
• Peptide pharmacology
• Peptide chemistry
• Protein–peptide interaction research
• Biochemical research
• Cell-based research
• Experimental peptide science
• Molecular pharmacology
• Preclinical research

Researchers should establish experimental conditions, controls, analytical methods, storage requirements, and handling procedures according to validated laboratory protocols and institutional requirements. This product description does not constitute an experimental protocol or recommended method of use.

---

Research Material & Quality Considerations

Reliable peptide research depends on appropriately characterized research materials. When evaluating CJC-1295 (No DAC), researchers should consider documentation associated with the applicable production batch.

Relevant documentation may include:

• Peptide identity
• Purity information
• Batch identification
• Analytical testing
• Molecular characterization
• Certificate of Analysis, where available
• Storage specifications
• Product documentation

Researchers should review the applicable batch documentation before incorporating the material into experimental investigations.

---

Why CJC-1295 (No DAC) Is Relevant to Research

CJC-1295 (No DAC) provides researchers with an experimental model for studying the relationship between modified peptide structure, GHRH receptor biology, peptide signaling, and intracellular molecular pathways.

Its research relevance spans:

• GHRH receptor signaling
• GPCR biology
• Growth-hormone-related molecular research
• Peptide–receptor interactions
• Molecular endocrinology
• Peptide chemistry
• Cellular communication
• Molecular biology
• Receptor pharmacology
• Biochemical research
• Experimental peptide science
• Preclinical research

This makes CJC-1295 (No DAC) suitable for multidisciplinary laboratory investigations involving peptide science, receptor biology, molecular signaling, and experimental endocrinology.

---

Research Use Only

CJC-1295 (No DAC) is supplied strictly as a laboratory research material.

It is not intended for human or veterinary use and should not be represented as a medication, dietary supplement, performance product, or therapeutic treatment. Experimental findings should not be presented as established evidence of safety or efficacy for human use.

Researchers are responsible for ensuring that research materials are handled, stored, evaluated, and disposed of according to appropriate laboratory procedures, institutional requirements, and applicable regulations.

Research Use Only. Not for Human or Veterinary Use.